FDA 483 - MedImmune U.K. Limited - March 15, 2024
FDA 483 for MedImmune U.K. Limited on March 15, 2024. Product: biologics. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA 483 for MedImmune U.K. Limited on March 15, 2024. Product: biologics. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
MedImmune U.K. LimitedInspection Date
March 15, 2024
Product Type
biologics
ID: 7412f120-467e-4587-9e8c-bfae5fcb83d0
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox